Champions Oncology Inc.
CSBR | NASDAQ
$4.81
$0.00 (0.00%)
At close: Oct 30, 2026, 4:00 PM ET
$4.81
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2026 Apr 30, 2026 | FY 2025 Apr 30, 2025 | FY 2024 Apr 30, 2024 | FY 2023 Apr 30, 2023 | FY 2022 Apr 30, 2022 | FY 2021 Apr 30, 2021 |
|---|---|---|---|---|---|---|
PE Ratio | -74.50 | 21.03 | -8.98 | -12.46 | 185.06 | 388.77 |
PEG Ratio | 0.60 | -0.13 | -0.23 | 0.01 | 3.67 | -3.37 |
PS Ratio | 1.39 | 1.72 | 1.31 | 1.22 | 2.06 | 3.44 |
PB Ratio | 20.93 | 25.89 | -34.53 | 14.20 | 11.14 | 18.98 |
P/FCF Ratio | -16.37 | 13.96 | -9.42 | 60.77 | 24.64 | -28.41 |
P/OCF Ratio | -18.43 | 13.22 | -10.71 | 16.64 | 15.60 | -83.87 |
OCF/S Ratio | -7.53 | 12.97 | -12.24 | 7.34 | 13.23 | -4.10 |
Debt / Equity Ratio | 1.15 | 1.62 | -3.90 | 1.85 | 1.04 | 1.29 |
Quick Ratio | 0.96 | 0.94 | 0.63 | 0.90 | 1.13 | 1.13 |
Current Ratio | 0.96 | 0.94 | 0.63 | 0.90 | 1.13 | 1.13 |
Asset Turnover | 2.20 | 1.76 | 1.92 | 1.57 | 1.39 | 1.49 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -29.83% | 124.63% | 382.34% | -115.08% | 6.02% | 4.87% |
Return on Assets | -4.35% | 14.53% | -27.84% | -15.55% | 1.55% | 1.31% |
Return on Invested Capital | -13.28% | 48.64% | -116.24% | -32.27% | 3.01% | 1.76% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 48% | 50.15% | 41.38% | 45.18% | 51.88% | 47.74% |
Net Profit Margin | -1.98% | 8.26% | -14.51% | -9.90% | 1.12% | 0.88% |
Pretax Profit Margin | -1.56% | 8.12% | -14.57% | -9.78% | 1.19% | 1.06% |
Operating Profit Margin | -1.92% | 8.51% | -13.80% | -8.26% | 1.24% | 0.89% |
FCF Margin | -8.47% | 12.29% | -13.90% | 2.01% | 8.38% | -12.09% |
EBITDA Margin | 0.75% | 11% | -10.85% | -5.61% | 4.50% | 3.78% |
Add to Watchlist
Select watchlists to add or remove CSBR